Tacrolimus (FK506) prevents early retinal neovascularization in streptozotocin-induced diabetic mice

Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 Watkins, 2003, ABC of diabetes-retinopathy, BMJ, 326, 924, 10.1136/bmj.326.7395.924 Murdoch, 2005, Hypoxia regulates macrophage functions in inflammation, J Immunol, 175, 6257, 10.4049/jimmunol.175.10.6257 Tang, 2011, Inflammation in diabetic retinopathy, Prog Retin Eye Res, 30, 343, 10.1016/j.preteyeres.2011.05.002 Adamis, 2008, Immunological mechanisms in the pathogenesis of diabetic retinopathy, Semin Immunopathol, 30, 65, 10.1007/s00281-008-0111-x Joussen, 2004, A central role for inflammation in the pathogenesis of diabetic retinopathy, FASEB J, 18, 1450, 10.1096/fj.03-1476fje Adamis, 1999, Angiogenesis and ophthalmic disease, Angiogenesis, 3, 9, 10.1023/A:1009071601454 Ishida, 2003, VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization, J Exp Med, 198, 483, 10.1084/jem.20022027 Nagai, 2007, Suppression of diabetes-induced retinal in flammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway, Invest Ophthalmol Vis Sci, 48, 4342, 10.1167/iovs.06-1473 Todo, 1990, Liver, kidney, and thoracic organ transplantation under FK 506, Ann Surg, 212, 295, 10.1097/00000658-199009000-00008 Baumgart, 2006, Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease—a long-term follow-up, Am J Gastroenterol, 101, 1048, 10.1111/j.1572-0241.2006.00524.x Thestrup-Pedersen, 2003, Tacrolimus treatment of atopic eczema/dermatitis syndrome, Curr Opin Allergy Clin Immunol, 3, 359, 10.1097/00130832-200310000-00007 Zeyda, 2007, Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappaB in immunological synapse formation, J Leukoc Biol, 81, 319, 10.1189/jlb.0606378 Du, 2009, Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response, J Immunol, 182, 7201, 10.4049/jimmunol.0801772 Yoshino, 2010, Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis, Inflamm Bowel Dis, 16, 2022, 10.1002/ibd.21318 Nakamura-Yanagidaira, 2011, Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation, Mol Vis, 17, 2157 Sharma, 1985, A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats, Am J Ophthalmol, 100, 51, 10.1016/S0002-9394(14)74982-7 Mizutani, 1996, Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy, J Clin Invest, 97, 2883, 10.1172/JCI118746 Oh-i, 2007, Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in rats, Br J Ophthalmol, 91, 237, 10.1136/bjo.2006.103168 Spierer, 2005, An increase in superoxide dismutase ameliorates oxygen-induced retinopathy, Eye (Lond), 19, 86, 10.1038/sj.eye.6701424 Otani, 2004, Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells, J Clin Invest, 114, 765, 10.1172/JCI200421686 Jockovich, 2008, Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy, Retina, 28, S81, 10.1097/IAE.0b013e318150d6f0 Tsai, 2009, Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats, Clin Experiment Ophthalmol, 37, 223, 10.1111/j.1442-9071.2009.02000.x Schnedl, 1994, STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells, Diabetes, 43, 1326, 10.2337/diab.43.11.1326 Satofuka, 2009, (Pro)renin receptor-mediated signal transduction and tissue renin–angiotensin system contribute to diabetes-induced retinal inflammation, Diabetes, 58, 1625, 10.2337/db08-0254 Brockman, 1995, Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation, Mol Cell Biol, 15, 2809, 10.1128/MCB.15.5.2809 Brown, 1995, Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation, Science, 267, 1485, 10.1126/science.7878466 DiDonato, 1996, Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation, Mol Cell Biol, 16, 1295, 10.1128/MCB.16.4.1295 Baldwin, 1996, The NF-kappa B and I kappa B proteins: new discoveries and insights, Annu Rev Immunol, 14, 649, 10.1146/annurev.immunol.14.1.649 Yoshida, 1999, Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice, Invest Ophthalmol Vis Sci, 40, 1624 Krady, 2005, Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy, Diabetes, 54, 1559, 10.2337/diabetes.54.5.1559 Wang, 2006, Nuclear factor-kappaB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats, Brain Res, 1081, 211, 10.1016/j.brainres.2006.01.077